Noumi Limited
FRDZF
Other OTC0.09
USD
- -
- -
Noumi Limited
FRDZF
(Other OTC)
Recent
price
0.09
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Noumi Limited Noumi Limited (ASX:NOU) manufactures, markets, sells and distributes dairy and plant-based beverages along with nutritional products primarily in Australia, New Zealand, China, Southeast Asia, South Africa and the Middle East; it operates through two main segments including Dairy & Nutritionals and Plant-based Milks. The company offers a diverse portfolio of products such as full cream, skim, low fat, lactose-free, flavoured and fortified specialty milks; creams; protein drinks including Vital Strength and Uprotein brands; dietary supplements like Crankt; nutritional powders; plant-based milks encompassing almond, soy, oat, coconut, macadamia and other varieties under brands including MILKLAB, Australia's Own and So Natural; and specialized ingredients such as PUREnFERRIN lactoferrin. Founded in 1984 and headquartered in Ingleburn, New South Wales, Australia, Noumi Limited, formerly Freedom Foods Group Limited until its name change in November 2021, is a subsidiary of Arrovest Pty Limited and conducts operations through subsidiaries like Noumi Operations Pty Ltd, Noumi Trading Pty Ltd and Noumi Dairy Trading Pty Ltd across facilities in New South Wales and Victoria; it employs approximately 524 people and targets consumer and business markets in health, wellness and fitness sectors. Recent developments include new milk supply agreements commencing 1 July 2024 aligned with long-term business objectives; strategic distribution partnerships launched in five key export markets during FY24 boosting plant-based export sales by 26.6% in HY25; a May 2024 retail launch of the market-leading Milklab brand with its reformulated oat milk achieving 31.5% sales growth; finalization of a class action settlement in September 2025; renewal of CEO Michael Perich's contract in November 2025 from a fixed term ending December 2025 to an indefinite term to support ongoing transformation; and successful passage of all resolutions at the 2025 Annual General Meeting including re-election of directors, adoption of the remuneration report and approval of the equity incentive plan.